1443021-58-6

Basic information

• Product Name: 1-[(E)-3-(4-[1,3]dioxolan-2-yl-2-methoxy-phenyl)-allyl]-pyrrolidine-2,5-dione
• Synonyms: 1-[(E)-3-(4-[1,3]dioxolan-2-yl-2-methoxy-phenyl)-allyl]-pyrrolidine-2,5-dione
• CAS NO: 1443021-58-6
• Molecular Weight: 317.342
• Mol File: 1443021-58-6.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 1-[(E)-3-(4-[1,3]dioxolan-2-yl-2-methoxy-phenyl)-allyl]-pyrrolidine-2,5-dione(CAS DataBase Reference)
• NIST Chemistry Reference: 1-[(E)-3-(4-[1,3]dioxolan-2-yl-2-methoxy-phenyl)-allyl]-pyrrolidine-2,5-dione(1443021-58-6)
• EPA Substance Registry System: 1-[(E)-3-(4-[1,3]dioxolan-2-yl-2-methoxy-phenyl)-allyl]-pyrrolidine-2,5-dione(1443021-58-6)

Safety Data

• Hazardous Substances Data: 1443021-58-6(Hazardous Substances Data)

Upstream product

• 194018-68-3 vanillin triflate 
• 2555-14-8 N-allylsuccinimide 
• 1443021-57-5 trifluoro-methanesulfonic acid 4-[1,3]dioxolan-2-yl-2-methoxy-phenyl ester 
• 121-33-5 vanillin 

Downstream Products

• 1443021-63-3 4-[3-(2,5-dioxo-pyrrolidin-1-yl)-propyl]-3-methoxy-benzaldehyde 
• 1443021-67-7 4-[2-(2,5-dioxo-pyrrolidin-1-ylmethyl)-cyclopropyl]-3-methoxy-benzaldehyde 

Relevant articles and documents

Cycloalkane carboxylic acid derivatives as CXCR3 receptor antagonists

The present invention relates to compounds of formula 1 that are useful as an active ingredient of a medicament for preventive and/or therapeutic treatment of diseases caused by abnormal activation of CXCR3 chemokines. The invention relates furthermore to a process for the preparation of said compounds, to pharmaceutical compositions containing said compounds and to the novel intermediates used in the preparation of said compounds.

Substituted B-amino acid derivatives as CXCR3 receptor antagonist

The present invention relates to compounds of formula 1 that are useful as an active ingredient of a medicament for preventive and/or therapeutic treatment of diseases caused by abnormal activation of CXCR3 chemokines. The invention relates furthermore to a process for the preparation of said compounds, to pharmaceutical compositions containing said compounds and to the novel intermediates used in the preparation of said compounds.